Konstantin Kazankov is a consultant Hepatologist at the Department of Hepatology and Gastroenterology, Aarhus University Hospital and Clinical Associate Professor at Aarhus University.
He has earned his PhD degree investigating the role and biomarkers of macrophage activation in metabolic dysfunction-associated steatotic liver disease (MASLD). Furthermore, he has performed clinical research in complications of cirrhosis, in particular cardiac abnormalities, portal hypertension and cirrhosis decompensation, including a groundbreaking study of remote home management in patients with cirrhosis during his stay as a Senior Clinical Research Fellow at University College London and The Sheila Sherlock Liver Centre, Royal Free Hospital, London, UK.
His current research is focused on cardiac risk factors and outcomes in MASLD patients, as well as decompensated cirrhosis.